Brief Summary
Type:
Brain Tumors / Neurologic Cancers
Study Type:
Treatment
Phase:
II
ClinicalTrials.gov Identifier:
NCT04696029
Study #:
CMH - BCC016
Start Date:
Jun 27, 2021
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT04696029
View Complete Trial Details & Eligibility at ClinicalTrials.gov
